PRIMARY HIV CARE

• Introduction
• History and Ongoing Assessments
• Comprehensive Physical Examination
• Laboratory and Diagnostic Testing
• Health Promotion and Behavioral Counseling
• Preventive Medicine
• Immunizations for Adults With HIV
• Coordination of Care and Services
• All Recommendations

• Purpose and Development of This Guideline
• Burden and Implications of HPV-Related Anal Disease in Individuals With HIV
• Transmission and Prevention of HPV
• Screening
• Follow-Up of Abnormal Anal Cytology Results
• Treatment and Follow-Up
• All Recommendations
• How This Guideline Was Developed

• Purpose of this Guideline
• Preventing Cervical Cancer and Precancerous Lesions
• Screening for Cervical Abnormalities
• Follow-Up of Abnormal Pap Test Results
• Diagnosed Cervical Cancer
• All Recommendations
• How This Guideline Was Developed
• Updates to this Guideline

• Purpose of this Guideline
• Transmission and HAV Disease
• Prevention
• All Recommendations
• Updates to this Guideline

• Introduction
• Clinical Syndromes
• Baseline Evaluation and Screening
• Prevention
• Evaluation of Chronic HBV
• Counseling
• Treatment and Management
• Monitoring
• All Recommendations

See Treatment of Patients with HIV and HCV Coinfection in the guideline Treatment of Chronic HCV Infection with Direct-Acting Antivirals.

NYSDOH Meningococcal Vaccine Recommendations for HIV-Infected Individuals and Those at High Risk of HIV Infection: On June 22, 2016, ACIP voted to recommend that persons aged ≥2 months with HIV should receive meningococcal conjugate (MenACWY) vaccine, either MenACWY-D (Menactra®), MenACWY-CRM (Menveo®) or, as age-appropriate, Hib-MenCY-TT (MenHibrix®, recommended for ages 2-18 months). Download the 10/25/16 NYS Health Advisory | See previous advisories and alerts

For guidance on healthcare for transgender and non-binary individuals, please consult the World Professional Association for Transgender Health (WPATH) Standards of Care Version 7 and/or the University of California San Francisco (UCSF) Center of Excellence for Transgender Health Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People.

• Risks
• Preoperative Evaluation
• Perioperative Medication Management
• Postoperative Management
• All Recommendations

Oral health care is a critical component of comprehensive HIV medical management. Development of oral pathology is frequently associated with an underlying progression of HIV-disease status. A thorough soft-tissue examination may reveal pathology associated with dysphagia or odynophagia. Dental problems can result in or exacerbate nutritional problems. In addition, psychosocial and quality-of-life issues frequently are associated with the condition of the oral cavity and the dentition. See recommendations

• Introduction
• Linear Gingival Erythema (LGE)
• Necrotizing Ulcerative Gingivitis and Necrotizing Ulcerative Periodontitis (NUG/NUP)
• Necrotizing Ulcerative Stomatitis and Necrotizing Stomatitis (NUS/NS)
• Chronic Pre-Existing Periodontal Disease
• All Recommendations
• Appendix: Photo- and Radiographs of Periodontal Disease Associated with HIV Infection
• How This Guideline Was Developed

• Quick Reference Guides
• Online Resources for Education, Information and Services
• HIV Care Provider Definitions
• June 2016 Policy Statement: Defining Program Eligibility by HIV Status
• All FDA-Approved HIV Medications
• ARV Drug Name Abbreviation Key
• Mental Health Screening Tools
• GOALS Framework for Sexual History Taking in Primary Care

• Online Resources for Education, Information, and Services
• Consumer Q/A: Starting Antiretroviral Therapy (ART) for HIV
• Consumer Q/A: IRIS in People Who Take ART for HIV Infection

• U=U Guidance for Implementation in Clinical Settings
• HPV in Patients with HIV
• Management of Syphilis in Patients with HIV
• Management of Gonorrhea and Chlamydia in Patients with HIV
• CEI for Clinical Training in HIV, STIs, and HCV
• CEI ECHO (HIV)
• CEI ECHO (STD)